SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently the focus of intense investor scrutiny as shareholders, led by activist investor Shah Capital, escalate pressure on the board to address stagnant stock performance and executive compensation ahead of the upcoming June shareholder meeting. The community is actively debating the company's long-term potential, with bullish sentiment anchored in the proprietary Matrix-M adjuvant technology and potential oncology applications, while bearish voices remain focused on management's lack of transparency and failure to monetize key assets like the COVID-influenza combination vaccine.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending amid persistent market volatility driven by conflicting reports surrounding a potential peace deal with Iran. Investors are closely monitoring the impact of ongoing Strait of Hormuz tensions, significant crude inventory drawdowns, and the repetitive cycle of diplomatic rumors that continues to trigger rapid swings in energy sentiment.

Tidal Trust II - YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF

Investors in the YieldMax COIN Option Income Strategy ETF (CONY) are actively debating the merits of a 'hold and harvest' strategy, highlighting the fund's role as a monthly cash flow engine despite concerns over NAV erosion. The community is heavily focused on the trade-off between collecting high-yield distributions and the long-term impact on principal, with many shareholders emphasizing the importance of reinvestment to build share count and lower cost basis over time.

Story is a purpose-built layer 1 blockchain designed specifically to onramp intellectual property (IP) to the blockchain and make it programmable.  Story tokenizes any type of IP; whether that’s an idea, an image, a real world asset, a song, an AI model, an NFT or anything in-between. By embedding usage terms, attribution, and royalty agreements directly into the blockchain, Story provides a transparent, decentralized solution for IP management. This enables IP holders to protect their work, collaborate on IP seamlessly, and unlock revenue opportunities in an AI-powered economy.

Story Protocol

Story Protocol's $IP.X token is experiencing significant community buzz driven by its role as AI-native infrastructure for programmable intellectual property, with traders heavily focused on its potential as a long-term AI data narrative. The community is actively debating the stock's volatility and its relationship with the public equity vehicle IPST, while many users speculate on the token's upside due to its circulating supply and emerging role in AI training data harvesting.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing significant community debate as investors navigate the high-volatility 

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market discussions as investors react to geopolitical instability surrounding U.S.-Iran negotiations and a flurry of high-level diplomatic meetings. The community is actively debating the sustainability of current record-high market valuations against a backdrop of sticky inflation, elevated Treasury yields, and skepticism regarding the long-term impact of AI-driven capital expenditure.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is seeing significant market activity as investors weigh strong Q1 earnings results, featuring a 50% increase in EBITDA guidance, against ongoing volatility driven by Middle East geopolitical tensions and speculation over potential energy deals. While the community remains divided over the stock's sensitivity to war headlines versus its long-term fundamentals, many are actively monitoring insider activity and supply deficit projections as catalysts for a potential re-rating.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is trending as traders closely monitor geopolitical tensions and potential breakthroughs in Middle East peace negotiations, which remain the primary catalyst for market volatility. Community members are actively debating the legitimacy of these 'peace deals' versus the ongoing reality of supply chain disruptions in the Strait of Hormuz, with many positioning for short-term reversals while others look for signs of a broader market rotation.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space Inc is seeing heightened trading activity and intense community debate as investors speculate on potential industry contracts, the impact of recent leadership transitions, and its strategic positioning ahead of the highly anticipated SpaceX IPO. While some investors are bullish on the company's supersonic platform and long-term space sector potential, others are actively highlighting risks related to cash burn, ongoing legal challenges, and the potential for share dilution.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending as retail investors speculate on its role in the autonomous drone software sector, with community discussion intensely focused on potential government contracts and the company's perceived potential to become a dominant defense industry player. The stock continues to experience high volatility and strong retail interest, driven by ongoing geopolitical tensions and the narrative that its battle-tested swarm technology represents a critical advancement in modern military warfare.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch

Key PointsProsight Management increased its Nektar Therapeutics holding by 180,367 shares last quarter, an estimated $10.27 million buy based on average prices during the quarter...

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

NKTR misses Q1 earnings and revenue estimates. Investor focus stays on rezpeg as the company advances late-stage studies in autoimmune diseases.

Nektar Therapeutics Reports First Quarter 2026 Financial Results

Nektar Therapeutics Reports First Quarter 2026 Financial Results Nektar Therapeutics Reports First Quarter 2026 Financial Results PR Newswire SAN FRANCISCO, May 7, 2026 SAN FRANCISCO, May 7, 2026...

NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Nektar Therapeutics Lawsuit - NKTR

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Nektar Therapeutics Lawsuit - NKTR The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May...

NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit PR Newswire NEW YORK, May 4, 2026 NEW YORK, May 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a...

Deadline Soon: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors...

Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of "Moderate Buy" by Analysts

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating an...

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to...

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

NKTR
Nektar Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest NKTR News

NKTRNektar Therapeutics